bcv

BCV is pioneering a novel class of endovascular device with its first-generation actuable mechatronic guidewire, designed to improve access and navigation in complex vascular anatomies. The technology, which features a smart handle and a Shape Memory Alloy-actuated tip, aims to make procedures faster, safer, and compatible with robotic and AI-assisted platforms. Co-founded by an interventional neuroradiologist and engineering experts from Sorbonne University, the startup is supported by French and EU innovation grants and is positioned to address a significant unmet need in interventional medicine. Its platform has broad applicability beyond its initial cardiovascular and neurovascular focus.

Active mechatronic guidewire system using a smart handle for electronic control and Shape Memory Alloy (SMA) actuators embedded in the guidewire tip for precise, remote steering and navigation through tortuous vasculature. Designed for compatibility with existing catheters, imaging systems, and future robotic/AI platforms.

BCV competes in the large, established guidewire market dominated by giants like Medtronic, Boston Scientific, and Terumo. Its value proposition is not a direct replacement but a paradigm shift to an active, digitally controlled device. Near-term competitors are other early-stage companies developing steerable or robotic guidewires. The long-term competitive threat is the R&D arms of the large incumbents, who could rapidly develop similar technology if the market is validated.